abstract |
The present invention relates to a stable pharmaceutical composition of a combination of a calcium channel blocker and an ACE inhibitor; wherein the two active ingredients are not physically separated and the composition has a pH of more than 6.0. It also relates to a process for preparation, and a method for using such a composition. |